Overview
Vitiligo-associated autoimmune disease refers to a group of autoimmune conditions that tend to occur together with vitiligo, a skin condition where patches of skin lose their color (pigment). This entry in medical databases has been marked as 'OBSOLETE,' meaning it is no longer used as a standalone diagnosis. Instead, the individual conditions that make up this grouping are now classified separately. Vitiligo itself is a condition where the immune system mistakenly attacks the melanocytes — the cells that give skin its color — leading to white patches on the skin. People with vitiligo have a higher-than-average chance of developing other autoimmune diseases, including autoimmune thyroid disease (such as Hashimoto's thyroiditis or Graves' disease), type 1 diabetes, pernicious anemia, Addison's disease, rheumatoid arthritis, and alopecia areata (patchy hair loss). This clustering of autoimmune conditions suggests shared genetic and immune system factors. Treatment focuses on managing each individual autoimmune condition. For vitiligo itself, treatments include topical creams, light therapy, and newer targeted medications. Because this term is obsolete, patients are encouraged to seek information under the specific autoimmune conditions they have been diagnosed with.
Key symptoms:
White or light patches on the skinLoss of skin color, especially on the face, hands, and around body openingsPremature graying of hair on the scalp, eyebrows, or eyelashesFatigue and tirednessUnexplained weight changesFeeling cold or heat intolerantPatchy hair lossTingling or numbness in hands and feetJoint pain or stiffnessIncreased thirst and frequent urinationDizziness or lightheadednessDifficulty concentrating or brain fogDry skin
Multifactorial
Caused by a mix of several genes and environmental factors
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for OBSOLETE: Vitiligo-associated autoimmune disease.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for OBSOLETE: Vitiligo-associated autoimmune disease at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for OBSOLETE: Vitiligo-associated autoimmune disease.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to OBSOLETE: Vitiligo-associated autoimmune disease.
Community
No community posts yet. Be the first to share your experience with OBSOLETE: Vitiligo-associated autoimmune disease.
Start the conversation →Latest news about OBSOLETE: Vitiligo-associated autoimmune disease
No recent news articles for OBSOLETE: Vitiligo-associated autoimmune disease.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.Should I be screened for other autoimmune conditions, and how often?,What treatment options are best for my specific pattern of vitiligo?,Are my family members at increased risk, and should they be tested?,What are the signs that a new autoimmune condition may be developing?,Is ruxolitinib cream (Opzelura) or phototherapy a good option for me?,How can I protect my mental health while managing these conditions?,What emergency situations should I be prepared for, and what should I do?
Common questions about OBSOLETE: Vitiligo-associated autoimmune disease
What is OBSOLETE: Vitiligo-associated autoimmune disease?
Vitiligo-associated autoimmune disease refers to a group of autoimmune conditions that tend to occur together with vitiligo, a skin condition where patches of skin lose their color (pigment). This entry in medical databases has been marked as 'OBSOLETE,' meaning it is no longer used as a standalone diagnosis. Instead, the individual conditions that make up this grouping are now classified separately. Vitiligo itself is a condition where the immune system mistakenly attacks the melanocytes — the cells that give skin its color — leading to white patches on the skin. People with vitiligo have a h
How is OBSOLETE: Vitiligo-associated autoimmune disease inherited?
OBSOLETE: Vitiligo-associated autoimmune disease follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.